Intravesical Bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer

Review of 12 RCTs (n=2932) found BCG may reduce risk of recurrence but confidence intervals (CIs) include possibility of no difference. BCG may cause more serious adverse events although CIs include possibility of no difference. Impact on quality of life could not be determined.

Source:

Cochrane Database of Systematic Reviews